Skip to main content
RPRX
NASDAQ Life Sciences

Royalty Pharma Raises 2026 Guidance as Royalty Receipts Jump 14%

Tom Rudovsky · Reported by dpa-AFX
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$58.62
Mkt Cap
$33.102B
52W Low
$34.081
52W High
$60.44
52W Position info
72% above low
Off High info
3.0% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

RPRX sits 72% above its 52-week low of $34.081.

Summary

Royalty Pharma raised its full-year 2026 Portfolio Receipts guidance to $3.4–$3.5 billion, up from $3.325–$3.45 billion, driven by a 14% jump in Q2 Royalty Receipts to $768 million. Key growth drivers include Tremfya, Voranigo, Imdelltra, and Evrysdi. Adjusted EBITDA rose to $736 million from $633 million, though net income fell to $18 million from $32 million due to non-cash charges. The raised outlook signals stronger-than-expected royalty performance, and shares edged up 1.17% pre-market. This follows a recent 8-K filing this morning with preliminary Q2 figures and the guidance raise.

At the time of this announcement, RPRX was trading at $58.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $33.1B. The 52-week trading range was $34.08 to $60.44. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

RPRX - Latest Insights

RPRX
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $66.20
Real-time Price: $66.20 info
Change: $0 (0%) info
Market Cap: $38.273B info
RPRX
Nov 04, 2026, 7:38 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $66.40
Real-time Price: $66.20 info
Change: -$0.200 (-0.30%) info
Market Cap: $38.273B info
RPRX
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $66.58
Real-time Price: $66.20 info
Change: -$0.380 (-0.57%) info
Market Cap: $38.273B info
RPRX
Aug 12, 2026, 5:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $59.22
Real-time Price: $66.20 info
Change: +$6.98 (+12%) info
Market Cap: $38.273B info
RPRX
Aug 05, 2026, 9:02 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $57.69
Real-time Price: $66.20 info
Change: +$8.51 (+15%) info
Market Cap: $38.273B info